Patent Assignment
Reel/Frame 062794/0546
Assignment of Assignor's Interest
Recorded: 2023-02-17
Pages: 33
Assignor
KNOPP BIOSCIENCES LLC
Executed: 2022-06-24
Assignee
ARETEIA THERAPEUTICS, INC.
101 LENNOX DRIVE, SUITE 300, CHAPEL HILL, NORTH CAROLINA, 27517
Covered Properties
(3)
Compositions and Methods for Treating Chronic Urticaria
Compositions and Methods for Treating Chronic Urticaria
Compositions and Methods for Treating Chronic Idiopathic Urticaria
Application:
61/865,583 →
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 17, 2014
From: BOZIK, MICHAEL E.
To: KNOPP BIOSCIENCES LLC
Reel/Frame 032456/0905 →
Assignment of Assignor's Interest
Mar 27, 2014
From: KNOPP NEUROSCIENCES INC.
To: KNOPP BIOSCIENCES LLC
Reel/Frame 032551/0311 →
Security Interest
May 22, 2014
From: KNOPP BIOSCIENCES LLC
To: KOPPER, RACHEL
Reel/Frame 032992/0899 →
Assignment of Assignor's Interest
Mar 3, 2016
From: BOZIK, MICHAEL E.; DWORETZKY, STEVEN
To: KNOPP BIOSCIENCES LLC
Reel/Frame 037883/0101 →
Assignment of Assignor's Interest
Mar 3, 2016
From: BOZIK, MICHAEL E.; DWORETZKY, STEVEN
To: KNOPP BIOSCIENCES LLC
Reel/Frame 037883/0129 →
Assignment of Assignor's Interest
Oct 26, 2017
From: DWORETZKY, STEVEN
To: KNOPP BIOSCIENCES LLC
Reel/Frame 043956/0199 →
Assignment of Assignor's Interest
Oct 26, 2017
From: BOZIK, MICHAEL E.
To: KNOPP BIOSCIENCES LLC
Reel/Frame 043956/0148 →
Release of Security Interest
Feb 27, 2019
From: KOPPER, RACHEL
To: KNOPP BIOSCIENCES LLC
Reel/Frame 048455/0727 →
Security Interest
Apr 12, 2021
From: KNOPP BIOSCIENCES LLC
To: AMERICAN MONEY MANAGEMENT CORPORATION
Reel/Frame 055889/0064 →
Release of Security Interest
Apr 12, 2022
From: AMERICAN MONEY MANAGEMENT CORPORATION
To: KNOPP BIOSCIENCES LLC
Reel/Frame 059572/0530 →
Security Interest
Oct 10, 2025
From: ARETEIA THERAPEUTICS, INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 072540/0980 →
Release of Security Interest
Nov 21, 2025
From: HERCULES CAPITAL, INC., AS AGENT
To: ARETEIA THERAPEUTICS, INC.
Reel/Frame 072993/0621 →